Lialda Clinical Trials Lialda RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Condition:   Colorectal Cancer Interventions:   Drug: Mesalamine 2400 MG;   Drug: Mesalamine 1200 MG;   Other: Placebo Sponsors:   Christoph Gasche;   Prof. Dr. Gabriela Möslein, Germany;   Prof. Dr. Hans Vasen, The Netherlands;   Prof. Dr. med. Jan Lubinski, Poland;   Prof. Dr. med. Yaron Niv, Israel;   Univ. Prof. Dr. Judith Karner-Hanusch, Austria;   Ann-Sofie Backman, MD PhD, Sweden Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2017 Category: Research Source Type: clinical trials

Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Condition:   Colorectal Cancer Interventions:   Drug: Mesalamine 2400 MG;   Drug: Mesalamine 1200 MG;   Other: Placebo Sponsors:   Christoph Gasche;   Prof. Dr. Gabriela Möslein, Germany;   Prof. Dr. Hans Vasen, The Netherlands;   Prof. Dr. med. Jan Lubinski, Poland;   Prof. Dr. med. Yaron Niv, Israel;   Univ. Prof. Dr. Judith Karner-Hanusch, Austria;   Ann-Sofie Backman, MD PhD, Sweden Not yet recruiting - verified March 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2017 Category: Research Source Type: clinical trials